Kaitlin J. Mayne

May 3, 2024 | dom-pubs.onlinelibrary.wiley.com | Kaitlin J. Mayne |Glasgow Renal |Clyde Glasgow |Peter Hanlon

1 INTRODUCTION AND SCOPE OF REVIEW Globally, chronic kidney disease (CKD) is thought to affect about 9.5% of the population, or about 850 million people in total.1 In the context of ageing populations and the increasing prevalence of multimorbidity (including among younger people), the prevalence of CKD is set to rise further. By 2040, CKD is expected to be the fifth leading cause of death globally. CKD has a huge and growing economic impact.

Jun 27, 2023 | nature.com | Kaitlin J. Mayne |Jennifer Lees

IntroductionHypertension is both a precursor to and a sequela of chronic kidney disease (CKD). Hypertension is increasingly prevalent as kidney function declines and occurs in between 60 and 90% of individuals with CKD [1]. Optimisation of blood pressure control reduces cardiovascular risk in CKD and may slow kidney disease progression [1] thus blood pressure control is a critical component of CKD management.